News Conference News HFSA 2023 Semaglutide Works Across LVEF Range: STEP-HFpEF Analysis Todd Neale October 11, 2023
News Conference News ESC 2023 More Details on Acoramidis’ Benefit in ATTR Cardiomyopathy: ATTRibute-CM Michael O'Riordan August 31, 2023
News Conference News ESC 2023 STEP-HFpEF: Semaglutide Cuts Weight and Symptoms, Boosts Function Shelley Wood August 25, 2023
News Opinion Editor's Corner ESC 2023 What’s Going to Be Hot at ESC 2023? Shelley Wood August 15, 2023
News Daily News Study Finds No Increased Risk of CVD Years After Infertility Therapies L.A. McKeown August 11, 2023
News Daily News New Chronic Heart Disease Guidelines Update Roles of GDMT, Imaging, and Revascularization Michael O'Riordan July 20, 2023
News Daily News Takotsubo Trigger Type Matters, With Physical Shocks Linked to Worse Outcomes Shelley Wood July 19, 2023
News Daily News Global Numbers Paint Grim Picture of GDMT Uptake, Costs, and HF Outcomes Michael O'Riordan June 23, 2023
News Daily News CV Risk Disparities by Race/Ethnicity Persist in Childhood Cancer Survivors Yael L. Maxwell April 13, 2023
News Conference News ACC 2023 Viability Testing Fails to Find HF Patients Who’d Benefit From PCI in REVIVED-BCIS2 Michael O'Riordan March 09, 2023
News Conference News ACC 2023 Studies Support (Careful) Return to Sport for Athletes With Genetic Conditions Michael O'Riordan March 07, 2023
News Daily News FDA Advisors Recommend Against Approval of Omecamtiv Mecarbil Michael O'Riordan December 14, 2022
News Daily News Meth-Related HF: Challenges at the Intersection of CVD and Addiction Caitlin E. Cox December 06, 2022
News Daily News Myocarditis After COVID-19 Vaccination Less Serious Than Prepandemic Cases Todd Neale December 06, 2022
News Daily News Sodium Restriction No Help, No Harm in HF, Meta-analysis Confirms Shelley Wood November 23, 2022
News Conference News AHA 2022 Sizeable Minority of Pregnant Women Have CVD, US Data Show Caitlin E. Cox November 11, 2022